, a manganese-containing hepatobiliary contrast agent, is excreted in bile. We review the principles and practice of a contrast-enhanced MRC technique using mangafodipir and compare it with standard T2-weighted magnetic resonance cholangiography (MRC) sequences. Potential applications include the evaluation of leaks and strictures; the assessment of drainage in normal, surgically by-passed, stented and obstructed biliary systems; the diagnosis of cholecystitis; and the evaluation of normal and variant biliary anatomy. THE CURRENT PRACTICE of magnetic resonance cholangiography (MRC) relies on multi-planar thick and thin slice heavily T2-weighted (T2W) fast spin-echo techniques. These MR hydrographic sequences, while demonstrating anatomy, have a limited ability to demonstrate function.Mangafodipir trisodium (Teslascan™, Nycomed Amersham, Oslo, Norway) is an MR contrast agent that contains the paramagnetic metal, manganese (Mn 2ϩ ), which shortens the T1 relaxation time of neighboring protons, providing a positive contrast effect on T1-weighted (T1W) sequences. The manganese is bound to DPDP, a vitamin B6 analogue. Following intravenous injection, the manganese is removed from its DPDP ligand. The manganese binds to plasma proteins and is rapidly cleared from the blood. Seventy to 80% of the manganese is taken up by normal hepatocytes and the liver parenchyma becomes hyperintense on T1W sequences (1-3). The manganese is then transported into the bile, which also becomes hyperintense. A potential therefore exists to use this agent as a positive biliary magnetic resonance imaging (MRI) contrast agent on a T1W sequence.We aimed to demonstrate potential functional applications of a contrast-enhanced MRC technique (CE-MRC) using mangafodipir.
IMAGING TECHNIQUE
Contrast AdministrationThe standard recommended dose of mangafodipir is 0.005 mmol/kg (0.5 mL/kg). For the average 70 kg patient, this usually involves the slow intravenous administration of 35 mL of mangafodipir (0.35 mmol), followed by 20 mL of saline.
Imaging ProtocolOur current MRC protocol is based on a 1.5-T Siemens Symphony (Siemens Medical Systems, Erlangen, Germany) using a phased array coil. Our standard MRC protocol involves initial axial and coronal true fast imaging with steady state precession (FISP) sequences that are performed to localize the hepatobiliary tree. Coronal and coronal oblique thick slab MRC T2 TSE (4500/950/50 mm slab/512 matrix) and thin slice half-Fourier acquisition single-shot turbo spin-echo (HASTE) (ϱ/90 effective/4-mm slices/256 ϫ 512 matrix) MRC sequences are then performed. In most instances CE-MRC is not performed, and we would proceed to CE-MRC in less than 10% of cases.Without moving the patient, mangafodipir is administered as described above. Axial two-dimensional T1W sequences are performed at 10-minute intervals until there is adequate opacification of the biliary tree (typically 20 -30 minutes). At this time a three-dimensional coronal T1W gradient sequence (TR 6.2/TE 2.24/ 15°/32 partitions/effective thickness 1.8/f...